Sunday, October 19, 2025

AI-Guided Glaucoma Screening Shows Promise

New study shows machine learning algorithm significantly outperformed human graders at diagnosing glaucoma.

Friday, October 17, 2025

 Virtual Vision Health Announced New Features to Its Virtual Eye Platform 

The latest updates include additional language support, new Ocular Motility and Cover Testing modules, and multiexam integration.

Friday, October 17, 2025

Lumenis Announces Launch of Digital Duet 2.0

The company's digital SLT+YAG platform now features advanced HD imaging and seamless connectivity, among other features.

Thursday, October 16, 2025

Heru’s Wearable Diagnostic Achieves Milestone

The AI-powered device has tested 1 million eyes.

Thursday, October 16, 2025

Nordic Pharma to Feature Lacrifill, New Data at AAO 

Nordic Pharma, Inc. will feature Lacrifill Canalicular Gel, as well as recently published Lacrifill patient data and patient experience study results with attendees at AAO.

Wednesday, October 15, 2025

Iantrek Launches AlloFlo Uveo for Glaucoma

According to the company, AlloFlo Uveo is a first-of-its-kind surgical treatment targeting the uveoscleral pathway.

Tuesday, October 14, 2025

SpyGlass IOL System Shows Durable IOP Reduction in Study

Interim 24-month data from the BIM-IOL system demonstrate sustained IOP and medication reductions, along with improved visual acuity in glaucoma patients.

Monday, October 13, 2025

Rebranded IQity Debuts New Tech

The company formerly known as EyeQ Technologies will unveil new surgical and diagnostic tools at the AAO meeting this week in Orlando.

Monday, October 6, 2025

Verana Health Updates Data Tools

Integration and new variables aim to streamline clinical research and patient care.

Monday, October 6, 2025

Additional Denali Analyses Support NCX 470 NDA

The trial data shows sustained IOP lowering over 12 months. Nicox says it will submit a new drug application to the FDA in 2026.

Friday, September 26, 2025

Harrow Launches Patient Access Program

Harrow Access for All program will provide a portal for streamlined prescribing, affordability, and home delivery.

Friday, September 26, 2025

Harrow to Acquire Melt Pharmaceuticals

The acquisition centers on MELT-300, a sublingual sedation candidate. 

Thursday, September 25, 2025

FDA Approves Amneal’s Generic Bimatoprost

The company's bimatoprost ophthalmic solution 0.01% will be available in 2.5 mL, 5 mL, and 7.5 mL container sizes.

Thursday, September 18, 2025

Meta-Analysis Shows Strong Results for Omni System

Results presented at ESCRS demonstrate clinically significant, long-term reductions in IOP and medication use for the Omni.

Monday, September 15, 2025

Sagent Offers Travoprost Drop 

The IOP-lowering topical therapy represents the company’s first offering in ophthalmology.

Friday, September 12, 2025

Topcon Enters Mental Health Space With Senseye Investment

The technology will be integrated into the Harmony connected care platform, enabling broader diagnostic reach.

Tuesday, September 9, 2025

UnitedHealthcare Expands Glaucoma Surgical Policy

The policy change, which begins October 1, means greater access to innovative glaucoma treatments.

Tuesday, August 26, 2025

Glaucoma Surgical Device Market Poised for Growth

Next-generation subconjunctival shunts expected to drive rapid expansion through 2030.

Tuesday, August 26, 2025

First Patient Dosed in New Trial for EVP-Lowering Drug

The phase 2 Nightingale trial will evaluate Qlaris Bio's QLS-111 in patients with normal-tension glaucoma.

Thursday, August 21, 2025

Nicox Reports Denali Trial Data

In the phase 3 study, NCX 470 met the primary endpoint of noninferiority to latanoprost in lowering IOP.

Thursday, August 21, 2025

Iantrek Raises $42 Million to Launch AlloFlo Uveo

The Series C funding will support the commercial launch of the company’s biointerventional glaucoma therapy this fall.

Thursday, August 21, 2025

Glaucoma Research Foundation Receives Generous Gift

A $5 million donation from the Barry Foundation will support the development of neuroprotective therapies.

Wednesday, August 13, 2025

Myra Vision Wins FDA Approval to Initiate US IDE Study in Glaucoma    

The ADAPT study will evaluate the safety and effectiveness of the company’s Calibreye Titratable Glaucoma Therapy Surgical System.

By Rene Luthe

Friday, August 8, 2025

PolyActiva Launches US Trial of Glaucoma Implant

After promising results in Australia, the phase 2b trial will evaluate the safety and efficacy of PA5108 in 75 patients.

Tuesday, August 5, 2025

Alcon Agrees to Acquire Staar Surgical

The acquisition includes the EVO family of lenses for vision correction for patients with moderate to high myopia, with or without astigmatism.

Monday, July 7, 2025

Corza Medical Expands Onatec Suture Line

The company has added more than 100 products to its suture and needle portfolio.

Monday, July 7, 2025

Glaucoma Market Report Released

5-year compound annual revenue growth rates are forecasted to grow in emerging markets.

Tuesday, June 24, 2025

PER-001 Improves Visual Field in Glaucoma

The implant, which elutes an endothelin receptor antagonist, improved optic nerve structure and function independent of IOP lowering.

Tuesday, June 10, 2025

Proposed Combination Therapy Targets EVP and IOP

Qlaris Bio’s QLS-111-FDC would combine 2 mechanisms to improve glaucoma pressure control.

Friday, May 16, 2025

Nicox Maintains NDA Timeline After Whistler Trial

Exploratory results bolster understanding of NCX 470 without altering development path.

Wednesday, May 14, 2025

New World Medical Introduces Next Generation Streamline Surgical System

A new clear tip enhances surgical visibility.

Thursday, May 8, 2025

Perfuse Therapeutics Announces Data on PER-001 Intravitreal Implant for Glaucoma

The company says the phase 1/2a trial data support the potential of PER-001 as the first disease-modifying treatment for glaucoma.

Monday, April 28, 2025

SpyGlass Reports Data on Drug-Eluting IOL Platform

According to 18-month data presented at ASCRS, cataract patients who received the lenses showed clinically meaningful IOP reduction along with improved VA.

Tuesday, April 22, 2025

Sight Sciences Launches Omni Edge

Surgeons attending the ASCRS meeting this week can preview the new MIGS system.

Thursday, April 17, 2025

BVI’s Leos Laser Receives FDA 510(k) Clearance

The Laser Endoscopy Ophthalmic System is designed for early-stage glaucoma as well as a wide spectrum of glaucoma types.

Friday, March 21, 2025

Eyenovia, Betaliq Pursue Merger

The companies seek to combine their drug delivery technologies in a potential $92 million transaction.

Tuesday, March 18, 2025

Iantrek Reports Positive Results from Cyclodialysis Study

The bioreinforced cyclodialysis procedure using the CycloPen system reduced IOP and medication use over 2 years.

Tuesday, March 11, 2025

Topcon, RadiusXR, and Glaukos Launch Wearable Vision Test Platform

The Inspire device integrates diagnostic technology with patient education and data analysis.

Friday, March 7, 2025

Optos Expands Retinal Imaging Database

The enhanced dataset will help clinicians detect and manage eye diseases at an earlier stage.

Tuesday, March 4, 2025

Altris AI Launches Advanced Optic Disc Analysis for Glaucoma

The AI-powered Advanced Optic Disc Analysis module evaluates optic disc parameters using optical coherence tomography, providing personalized assessments by accounting for individual disc sizes and angle of rim absence.

Tuesday, March 4, 2025

Haag-Streit Launches the METIS 900 Ophthalmic Microscope

The new ophthalmic microscope system brings Haag-Streit’s optics into the operating room, providing sharp clarity and precision during ophthalmic surgeries.

Friday, February 28, 2025

Prevent Blindness Declares March Workplace Eye Wellness Month

The goal of the annual observance is to provide employers and employees with important information to help keep eyes safe and healthy at work.

Friday, February 21, 2025

Event Dedicated to Integrative Eye Health Scheduled

The Eye Health Summit, a new global patient-centered event dedicated to integrative eye health, will take place May 1-7 as a free hybrid event. 

Wednesday, February 19, 2025

Voyager DSLT Device Now Available in the US

Alcon’s automated laser enables treatment without a gonio lens or manual aiming.

Tuesday, February 18, 2025

VIA360 Surgical System Receives 510(k) Clearance

New World Medical's device can be used to deliver viscoelas­tic fluid and perform trabeculotomy.

Saturday, February 15, 2025

Optos Launches MonacoPro With Expanded Capabilities

The next-generation system integrates ultrawidefield imaging with improved diagnostic support.

Friday, February 14, 2025

Glenmark Launches Latanoprost Ophthalmic Solution 0.005%

Latanoprost Ophthalmic Solution, 0.005% (0.05 mg/mL) is a bioequivalent and therapeutically equivalent to the reference listed drug, Xalatan Ophthalmic Solution, 0.005% of Upjohn US 2 LLC, the company said in a press release.

Thursday, February 13, 2025

Virtual Eye Platform Expands Diagnostic Capabilities

The VR-based system now includes visual acuity testing alongside other eye exams.

Wednesday, February 5, 2025

QLS-111 Demonstrates Efficacy in Trials

Qlaris Bio reports positive phase 2 results for its investigational drug treatment QLS-111 in glaucoma and OHT patients.

Wednesday, February 5, 2025

Iantrek Appoints New CEO

Adam Szaronos takes over top leadership role from company founder Dr. Sean Ianchulev, who will remain involved as board chair and CMO.

Monday, February 3, 2025

BVI Medical Launches Educational Platform for Ophthalmic Surgeons

EyeXchange Solutions connects experienced and emerging surgeons across cataract, glaucoma, and retina specialties to share insights, refine techniques, and address complex cases. 

Thursday, January 23, 2025

AMA Prior Authorization Statement

The American Medical Association comments on a recent statement by US insurer UnitedHealth that it will work toward easing prior authorization rules.

Wednesday, January 22, 2025

Heidelberg Symposium to Showcase Glaucoma Innovations

The event will highlight the growing role of artificial intelligence in glaucoma diagnosis and management.

Tuesday, January 14, 2025

Bausch + Lomb, Glaucoma Research Foundation Launch Second Annual ‘Faces of Glaucoma’ Campaign and Fundraising Challenge

Throughout January, Bausch + Lomb and Glaucoma Research Foundation will spotlight educational resources and share stories of individuals and families living with glaucoma to raise awareness of the disease.

Monday, January 13, 2025

Bausch + Lomb Acquires Whitecap Biosciences

With innovative therapies addressing glaucoma and geographic atrophy currently in development, the acquisition of Whitecap Bioscience's strengthens B + L’s expanding clinical-stage pipeline. 

Tuesday, January 7, 2025

Canyon Labs Acquires iuvo BioScience’s Lab Division

The deal allows each company to focus on strengths.

Monday, January 1, 0001

FDA Clears Studyfor AvisiAqueous Shunt

The Investigational Device Exemption allows the SAPPHIRE trial of VisiPlate to move forward.